Nanobac Pharmaceuticals, Incorporated (NNBP) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Tampa, FL, 美国. 现任CEO为 John Stanton.
NNBP 拥有 IPO日期为 1994-10-31, 1 名全职员工, 在 Other OTC, 市值为 $24.95K.
Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It manufactures and markets in vitro diagnostic (IVD) kits, such as assays, antibodies, and reagents for detecting CNPs. The company's diagnostic assays comprise NANO-CAPTURE and NANO-SERO. Additionally, it conducts research and clinical studies in the development of urological diseases, including chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and polycystic kidney diseases, as well as cardiovascular diseases. Nanobac Pharmaceuticals, Incorporated was formerly known as HealthCentrics Inc. and changed its name to Nanobac Pharmaceuticals, Incorporated in December 2002. The company was founded in 1994 and is based in Tampa, Florida.
